RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...

RBC Capital analyst Gerard Cassidy maintained a Hold rating on Goldman Sachs Group (GS – Research ... Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management.

In a report released today, Niraj Shah from Goldman Sachs maintained a Buy rating on Incitec Pivot Limited (ICPVF – Research Report), with a ...

Goldman Sachs would consider acquisitions in asset and wealth management, but would be highly selective about any deal, CEO ...

Keefe, Bruyette & Woods analyst David Konrad reiterated an Outperform rating on the shares of Goldman Sachs Group Inc ... those looking to invest in capital markets, per the analyst.

Hedge funds last week jettisoned global stocks and added bets they would decline, said Goldman Sachs , just before U.S.

RBC Capital Markets head of global energy research Greg Pardy has made two changes to his Global Energy Best Ideas list, ...

Citi (C), JPMorgan Chase (JPM), Goldman Sachs (GS), and Wells Fargo (WFC) report on Wednesday, while Bank of America (BAC) and Morgan Stanley (MS) release results on Thursday. RBC Capital markets ...

Goldman Sachs exceeds revenue expectations in trading ... it is still considered an attractive option for those looking to invest in capital markets, per the analyst. Due to robust revenues ...